Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia

被引:16
|
作者
Tadege M. [1 ]
机构
[1] Department of Statistics, Injibara University, Injibara Amhara
关键词
ART; HIV; Survival; TB;
D O I
10.1186/s13104-018-3863-y
中图分类号
学科分类号
摘要
Objective: The purpose of this study was to identify the major risk factors, which contributed to shortened survival time to death of HIV patients on antiretroviral therapy. Six-hundred HIV patients were included from two hospitals and six health centers record from January 2003 to December 2017. Kaplan-Meier and Cox proportional hazard model were implemented. Results: From the Kaplan-Meier, log-rank test result indicated that there was a significant difference between tuberculosis comorbidity (P =.000), occupation (P =.027), and WHO clinical stage (P =.012) on the survival experience of patients at 5% statistical significance level. From the Cox regression result, the risk of death for patients who lived with tuberculosis was about 2.872-fold times higher than those patients who were negative. Most of the HIV/AIDS patients on antiretroviral therapy were died in a short period due to tuberculosis comorbidity, began with lower amount of CD4, being underweight, merchant, and being on WHO clinical stage IV. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [41] Antiretroviral therapy in patients infected with HIV-1.
    Corti, ME
    MEDICINA-BUENOS AIRES, 1998, 58 : 49 - 56
  • [42] ANTIRETROVIRAL THERAPY IN ADULT HIV-INFECTED PATIENTS
    SALZBERGER, B
    SCHRAPPE, M
    DIEHL, V
    INTERNIST, 1994, 35 (12): : 1095 - 1104
  • [43] Antiretroviral therapy for HIV-2 infected patients
    Smith, NA
    Shaw, T
    Berry, N
    Vella, C
    Okorafor, L
    Taylor, D
    Ainsworth, J
    Choudhury, A
    Daniels, RS
    El-Gadi, S
    Fakoya, A
    Moyle, G
    Oxford, J
    Tedder, R
    O'Shea, S
    de Ruiter, A
    Breuer, J
    JOURNAL OF INFECTION, 2001, 42 (02) : 126 - 133
  • [44] Renal function in a cohort of HIV-infected patients initiating antiretroviral therapy in an outpatient setting in Ethiopia
    Fiseha, Temesgen
    Gebreweld, Angesom
    PLOS ONE, 2021, 16 (01):
  • [45] High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia
    Alemu, Abere Shiferaw
    Kempker, Russell R.
    Tenna, Admasu
    Smitson, Christopher
    Berhe, Nega
    Fekade, Daniel
    Blumberg, Henry M.
    Aseffa, Abraham
    PLOS ONE, 2013, 8 (03):
  • [46] Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia
    Biadgilign, Sibhatu
    Deribew, Amare
    Amberbir, Alemayehu
    Deribe, Kebede
    BMC PEDIATRICS, 2008, 8 (1)
  • [47] Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia
    Sibhatu Biadgilign
    Amare Deribew
    Alemayehu Amberbir
    Kebede Deribe
    BMC Pediatrics, 8
  • [48] Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy
    Reus, S
    Portilla, J
    Gimeno, A
    Sánchez-Payá, J
    García-Henarejos, JA
    Martínez-Madrid, O
    Usó, J
    Roca, B
    Galindo, MJ
    López-Aldeguer, J
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2004, 22 (03): : 142 - 149
  • [49] CD4 COUNT AND THE RISK FOR DEATH IN PATIENTS INFECTED WITH HIV RECEIVING ANTIRETROVIRAL THERAPY
    YARCHOAN, R
    VENZON, DJ
    PLUDA, JM
    LIETZAU, J
    WYVILL, KM
    TSIATIS, AA
    STEINBERG, SM
    BRODER, S
    ANNALS OF INTERNAL MEDICINE, 1991, 115 (03) : 184 - 189
  • [50] Incident Pregnancy and Time to Death or AIDS among HIV-Positive Women Receiving Antiretroviral Therapy
    Westreich, Daniel
    Maskew, Mhairi
    Evans, Denise
    Firnhaber, Cindy
    Majuba, Pappie
    Sanne, Ian
    PLOS ONE, 2013, 8 (03):